ARTICLE | Company News
Eos and Aventis Pasteur in cancer pact
June 6, 2000 7:00 AM UTC
Eos Biotechnology (South San Francisco, Calif.) will use its genomics technology to identify, select and validate new targets for cancer vaccine products. Aventis Pasteur, a unit of Aventis (AVE), wil...